论文部分内容阅读
目的:探讨慢性阻塞性肺疾病(COPD)合并肺心病患者急性发作期采用低分子肝素治疗的临床效果。方法:以我院收治的90例老年COPD合并肺心病急性加重期患者为研究对象,随机分为对照组与治疗组,对照组行常规临床治疗,治疗组患者在此基础上加行低分子肝素抗凝治疗。比较两组患者治疗总有效率,以及血液流变学指标和血气分析指标差异,并进行统计学分析。结果:治疗组患者治疗总有效率显著高于对照组(88.9%vs 68.9%,P<0.05);治疗组患者血气分析及血液流变学指标均好于对照组。结论 :对COPD合并肺心病急性加重期患者采用低分子肝素抗凝治疗,可以明显改善血气分析和血液流变学指标,提高治疗有效率。
Objective: To investigate the clinical effect of low molecular weight heparin in acute exacerbation of chronic obstructive pulmonary disease (COPD) patients with pulmonary heart disease. Methods: Ninety elderly COPD patients with acute exacerbation of pulmonary heart disease admitted to our hospital were randomly divided into control group and treatment group. The control group received routine clinical treatment. Patients in treatment group were given low molecular weight heparin Anticoagulant therapy. The total effective rate of the two groups were compared, and the differences of hemorheology indexes and blood gas analysis indexes were also analyzed. Results: The total effective rate in the treatment group was significantly higher than that in the control group (88.9% vs 68.9%, P <0.05). The blood gas analysis and hemorheology indexes in the treatment group were better than those in the control group. Conclusion: Low molecular weight heparin anticoagulant therapy for COPD patients with acute exacerbation of pulmonary heart disease can significantly improve blood gas analysis and hemorheology, and improve the treatment efficiency.